140 related articles for article (PubMed ID: 1676872)
1. The role of gamma-glutamyl transpeptidase in hydroquinone-glutathione conjugate mediated nephrotoxicity.
Hill BA; Lo HH; Monks TJ; Lau SS
Adv Exp Med Biol; 1991; 283():749-51. PubMed ID: 1676872
[No Abstract] [Full Text] [Related]
2. Species differences in renal gamma-glutamyl transpeptidase activity do not correlate with susceptibility to 2-bromo-(diglutathion-S-yl)-hydroquinone nephrotoxicity.
Lau SS; Jones TW; Sioco R; Hill BA; Pinon RK; Monks TJ
Toxicology; 1990 Dec; 64(3):291-311. PubMed ID: 1980038
[TBL] [Abstract][Full Text] [Related]
3. Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.
Lau SS; Kleiner HE; Monks TJ
Drug Metab Dispos; 1995 Oct; 23(10):1136-42. PubMed ID: 8654203
[TBL] [Abstract][Full Text] [Related]
4. Differential uptake of isomeric 2-bromohydroquinone-glutathione conjugates into kidney slices.
Lau SS; McMenamin MG; Monks TJ
Biochem Biophys Res Commun; 1988 Apr; 152(1):223-30. PubMed ID: 2895999
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glutathion-S-yl)hydroquinone.
Peters MM; Jones TW; Monks TJ; Lau SS
Carcinogenesis; 1997 Dec; 18(12):2393-401. PubMed ID: 9450487
[TBL] [Abstract][Full Text] [Related]
6. The in vivo disposition of 2-bromo-[14C]hydroquinone and the effect of gamma-glutamyl transpeptidase inhibition.
Lau SS; Monks TJ
Toxicol Appl Pharmacol; 1990 Mar; 103(1):121-32. PubMed ID: 1969181
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and toxicity of 2-bromo-(diglutathion-S-yl)-hydroquinone and 2-bromo-3-(glutathion-S-yl)hydroquinone in the in situ perfused rat kidney.
Rivera MI; Hinojosa LM; Hill BA; Lau SS; Monks TJ
Drug Metab Dispos; 1994; 22(4):503-10. PubMed ID: 7956722
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of 2-(glutathion-S-yl)hydroquinone and 2,3,5- (triglutathion-S-yl)hydroquinone in the in situ perfused rat kidney: relationship to nephrotoxicity.
Hill BA; Davison KL; Dulik DM; Monks TJ; Lau SS
Toxicol Appl Pharmacol; 1994 Nov; 129(1):121-32. PubMed ID: 7974485
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity.
Elfarra AA; Jakobson I; Anders MW
Biochem Pharmacol; 1986 Jan; 35(2):283-8. PubMed ID: 2867768
[TBL] [Abstract][Full Text] [Related]
10. Glutathione, gamma-glutamyl transpeptidase, and the mercapturic acid pathway as modulators of 2-bromohydroquinone oxidation.
Monks TJ; Lau SS
Toxicol Appl Pharmacol; 1990 May; 103(3):557-63. PubMed ID: 1971126
[TBL] [Abstract][Full Text] [Related]
11. Glutathione conjugation as a mechanism of targeting latent quinones to the kidney.
Lau SS; Monks TJ
Adv Exp Med Biol; 1991; 283():457-64. PubMed ID: 1676871
[No Abstract] [Full Text] [Related]
12. Glutathione conjugates of 2-bromohydroquinone are nephrotoxic.
Monks TJ; Lau SS; Highet RJ; Gillette JR
Drug Metab Dispos; 1985; 13(5):553-9. PubMed ID: 2865102
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity of quinol/quinone-linked S-conjugates.
Monks TJ; Lau SS
Toxicol Lett; 1990 Sep; 53(1-2):59-67. PubMed ID: 1977217
[No Abstract] [Full Text] [Related]
14. In vivo nephrotoxic action of an isomeric mixture of S-(1-phenyl-2-hydroxyethyl)glutathione and S-(2-phenyl-2-hydroxyethyl)glutathione in Fischer-344 rats.
Chakrabarti S; Malick MA
Toxicology; 1991 Mar; 67(1):15-27. PubMed ID: 1673268
[TBL] [Abstract][Full Text] [Related]
15. 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants.
Monks TJ; Highet RJ; Lau SS
Mol Pharmacol; 1988 Oct; 34(4):492-500. PubMed ID: 3173333
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gamma-glutamyl transpeptidase potentiates the nephrotoxicity of glutathione-conjugated chlorohydroquinones.
Mertens JJ; Temmink JH; van Bladeren PJ; Jones TW; Lo HH; Lau SS; Monks TJ
Toxicol Appl Pharmacol; 1991 Aug; 110(1):45-60. PubMed ID: 1678558
[TBL] [Abstract][Full Text] [Related]
17. Gamma-glutamyl-glutathione. Natural occurrence and enzymology.
Abbott WA; Griffith OW; Meister A
J Biol Chem; 1986 Oct; 261(29):13657-61. PubMed ID: 2875999
[TBL] [Abstract][Full Text] [Related]
18. Influence of gamma-glutamyl transpeptidase inactivation on the status of extracellular glutathione and glutathione conjugates.
Reed DJ; Ellis WW
Adv Exp Med Biol; 1981; 136 Pt A():75-86. PubMed ID: 6124092
[No Abstract] [Full Text] [Related]
19. Early morphological and biochemical changes during 2-Br-(diglutathion-S-yl)hydroquinone-induced nephrotoxicity.
Rivera MI; Jones TW; Lau SS; Monks TJ
Toxicol Appl Pharmacol; 1994 Oct; 128(2):239-50. PubMed ID: 7940539
[TBL] [Abstract][Full Text] [Related]
20. The nephrotoxicity of 2,5-dichloro-3-(glutathion-S-yl)-1,4-benzoquinone, and 2,5,6-trichloro-3-(glutathion-S-yl)-1,4-benzoquinone is potentiated by ascorbic acid and AT-125.
Monks TJ; Lau SS; Mertens JJ; Temmink JH; van Bladeren PJ
Adv Exp Med Biol; 1991; 283():767-9. PubMed ID: 1676873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
